[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335259-105":59,"doc-detail-335259-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","the-atom-seq-sequence-capture-panel-can-accurately-predict-microsatellite-instability-status-in-formalin-fixed-tumour-samples-alongside-routine-gene-mutation-testing","The ATOM-Seq sequence capture panel can accurately predict microsatellite instability status in formalin-fixed tumour samples alongside routine gene mutation testing","","The ATOM-Seq targeted capture panel enables accurate prediction of microsatellite instability (MSI) status from formalin-fixed, paraffin-embedded tumour DNA while working alongside routine gene mutation testing. The mismatch repair (MMR) status from pathology reports was compared with MSI predictions derived from sequencing data. In 335 samples, MSI status was correctly classified in 314/319 samples (98.4% concordance). Reducing the number of MSI regions in silico still achieved comparable performance with as few as eight marker positions, supporting efficient integration into research or diagnostic workflows.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-atom-seq-sequence-capture-panel-can-accurately-predict-microsatellite-instability-status-in-formalin-fixed-tumour-samples-alongside-routine-gene-mutation-testing/335259/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-atom-seq-sequence-capture-panel-can-accurately-predict-microsatellite-instability-status-in-formalin-fixed-tumour-samples-alongside-routine-gene-mutation-testing/335259.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What does the ATOM-Seq sequence capture panel predict in this study?","Question",{"text":112,"@type":113},"It predicts microsatellite instability (MSI) status from formalin-fixed, paraffin-embedded tumour samples. Predictions are made from sequencing data alongside routine gene mutation testing.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was MSI prediction evaluated against clinical reference data?",{"text":117,"@type":113},"MMR status was obtained from routine pathology reports for each patient. The study compared those MMR-derived statuses with MSI predictions produced from the sequencing data.",{"name":119,"@type":110,"acceptedAnswer":120},"How many samples showed correct MSI classification, and what was the concordance rate?",{"text":121,"@type":113},"MSI status was correctly classified in 314 out of 319 samples, corresponding to 98.4% concordance. The remaining cases included sixteen failures.",{"name":123,"@type":110,"acceptedAnswer":124},"Can MSI performance be maintained with fewer MSI regions?",{"text":125,"@type":113},"Yes. After in silico reduction, comparable performance could be achieved using as few as eight MSI marker positions, while supporting efficiency in testing workflows.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},335259,1790640545,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":4},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe ATOM‑Seq sequence capture panel can accurately predict microsatellite instability status in formalin‑fixed tumour samples, alongside routine gene mutation testing  \nKanishta Srihar1, Arief Gusnanto2, Susan D. Richman1,5, Nicholas P. West1,5, Leanne Galvin1, Daniel Bottomley1,5, Gemma Hemmings1,5, Amy Glover1, Subaashini Natarajan1,  \nRebecca Miller1, Sameira Arif1, Hannah Rossington1,3, Thomas L. Dunwell4, Simon C. Dailey4, Gracielle Fontarum4, Agnes George4, Winnie Wu4, Phil Quirke1,5 & Henry M. Wood1,5*  \nMicrosatellite instability (MSI) occurs across a number of cancers and is associated with different clinical characteristics when compared to microsatellite stable (MSS) cancers. As MSI cancers have different characteristics, routine MSI testing is now recommended for a number of cancer types including colorectal cancer (CRC). Using gene panels for sequencing of known cancer mutations is routinely performed to guide treatment decisions. By adding a number of MSI regions to a small gene panel, the efficacy of simultaneous MSI detection in a series ofCRCs was tested. Tumour DNA from formalin‑fixed, paraffin‑embedded (FFPE) tumours was sequenced using a 23‑gene panel kit (ATOM‑Seq) provided by GeneFirst. The mismatch repair (MMR) status was obtained for each patient from their routine pathology reports, and compared to MSI predictions from the sequencing data. By testing 29 microsatellite regions in 335 samples the MSI status was correctly classified in 314/319 samples (98.4% concordance), with sixteen failures. By reducing the number of regions insilico, comparable performance could be reached with as few as eight MSI marker positions. This test represents a quick, and accurate means of determining MSI status in FFPE CRC samples, as part of a routine gene mutation assay, and can easily be incorporated into a research or diagnostic setting. This could replace separate mutation and MSI tests with no loss of accuracy, thus improving testing efficiency.  \nKeywords Microsatellite instability, Gene panel, Colorectal cancer, Mismatch repair  \nDeficient mismatch repair (dMMR) and the associated microsatellite instability (MSI) represent a subset of cancers with an association with Lynch syndrome and different clinical characteristics, outcomes and response to chemotherapy and immunotherapy when compared to proficient mismatch repair, microsatellite stable (pMMR/ MSS) tumours in similar anatomical sites. This is particularly relevant for colorectal cancer (CRC), where dMMR/ MSI is seen in approximately 12–17% of tumours, and is associated with older age, right-sidedness, better prognosis in intermediate stage disease, poorer response to standard chemotherapy and better response to immunotherapy1. Approximately 3% of CRC are associated with Lynch syndrome, which is caused by a germline mutation in the MMR genes and results in dMMR/MSI tumours, generally in younger patients2. In the UK, routine MMR/MSI testing of all CRC at diagnosis has been mandated by NICE since 2017 primarily to screen  \n1Pathology and Data Analytics, Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds, UK. 2Department of Statistics, University of Leeds, Leeds, UK. 3Leeds Institute of Data Analytics, University of Leeds, Leeds, UK. 4GeneFirst Ltd., Abingdon, UK. 5NIHR Leeds Biomedical Research Centre, Leeds, UK. *email: [h. m.wood@leeds.ac.uk](h. m.wood@leeds.ac.uk)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nfor Lynch syndrome, however the results are routinely used to guide neoadjuvant and adjuvant decisions, so quick and accurate detection is becoming increasingly important3.  \nDetection of dMMR is traditionally performed using immunohistochemistry (IHC) for four proteins; hMLH1, hMSH2, hMSH6 and PMS2, looking for loss of expression of one or more proteins in tumour cells. Alternatively, MSI has been directly measured usin","cbCairoiAU8FpuBo","https://ap.wps.com/l/cbCairoiAU8FpuBo","pdf",1075461,"English","# Background\n## Rationale for MSI testing\n\n# Methods\n## Sequencing with the ATOM-Seq 23-gene panel\n## Defining MSI from mismatch repair status\n## In silico reduction of MSI markers\n\n# Results\n## Concordance between predicted and pathology-defined MSI\n## Performance with reduced marker sets\n\n# Implications\n## Integration into routine mutation testing","[{\"question\":\"What does the ATOM-Seq sequence capture panel predict in this study?\",\"answer\":\"It predicts microsatellite instability (MSI) status from formalin-fixed, paraffin-embedded tumour samples. Predictions are made from sequencing data alongside routine gene mutation testing.\"},{\"question\":\"How was MSI prediction evaluated against clinical reference data?\",\"answer\":\"MMR status was obtained from routine pathology reports for each patient. The study compared those MMR-derived statuses with MSI predictions produced from the sequencing data.\"},{\"question\":\"How many samples showed correct MSI classification, and what was the concordance rate?\",\"answer\":\"MSI status was correctly classified in 314 out of 319 samples, corresponding to 98.4% concordance. The remaining cases included sixteen failures.\"},{\"question\":\"Can MSI performance be maintained with fewer MSI regions?\",\"answer\":\"Yes. After in silico reduction, comparable performance could be achieved using as few as eight MSI marker positions, while supporting efficiency in testing workflows.\"}]","The ATOM-Seq sequence capture panel can accurately predict microsatellite instability status in formalin-fixed tumour samples alongside routine gene mutation testing | PDF",1790010322,23]